Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Howard Colman, MD, PhD is a physician-scientist specializing in the treatment of brain tumors and the diagnosis and management of neurologic complications of cancer.
Cancer Care Posts
The state of Huntsman Cancer Institute is strong and focused, according to CEO Mary Beckerle, PhD. The annual presentation to faculty, staff, and students is a chance for Dr. Beckerle to reflect on accomplishments of the prior year and outline priorities for the future.
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Adam Cohen, MD, MS, was recently honored with a Huntsman Translational Scholar award. He is a researcher and physician, specializing in neuro-oncology and breast oncology.
With the recent news of Senator John McCain’s glioblastoma diagnosis, we asked the experts at Huntsman Cancer Institute about symptoms, diagnosis, and treatment of this cancer.
For tumors of the head and neck, surgery is often the first line of treatment. Head and neck surgical oncologists at Huntsman Cancer Institute perform the most complex procedures in the region for benign and malignant tumors of the thyroid, oral cavity, upper digestive tract, salivary glands, and other parts of the head and neck. Because these areas involve speech and swallowing, comprehensive care from an expert multidisciplinary team is crucial in decreasing complications and achieving the best possible outcomes for patients.
Are you thinking about taking part in a clinical trial? Read these five frequently asked questions about clinical trials.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of the Hematology Clinical Trials at Huntsman Cancer Institute and is also an Assistant Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.
Alvin Kwok, MD, MPH, is a breast reconstruction surgeon who returned to Utah to join the Huntsman Cancer Institute team. He shares with us how breast reconstruction can help patients' outlook on their cancer journey. We also find out what delicious activities he's up to on his days off.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Theresa Werner, MD, was recently honored with a Huntsman Translational Scholar award. She is the medical director of Clinical Trials and treats patients with gynecologic cancers.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Robert Andtbacka, MD, was recently honored with a Huntsman Translational Scholar award and will also lead the group for the coming year.
Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She talks with us about the optimistic women she treats in clinic and a stylish first lady of the United States she would trade lives with for a day.
Dr. Glen Bowen, my mentor, taught me the idea that the treatment team is like an octopus. Meaning, we are a single brain with eight arms. I’m an arm, the nurse is an arm, the scheduler is an arm—we are all an arm, and no arm is more or less important in caring for our patients.
This infographic highlights a few of Huntsman Cancer Institute's accomplishments in 2017.
Advancing discoveries made in the lab to medical treatments that can be used in patient care is complex and time-consuming. Commonly called clinical translation, this process can be thought of much like translating something from one language to another.
Everyone, including cancer patients and survivors, can lower the risk of developing certain types of cancer. If you have been diagnosed with cancer, these tips may lower your risk of developing a second cancer.
Tommy Tanzer, a resident of Park City, Utah, received three negative prostate biopsies over the course of three years, but he and his doctors still suspected he may have cancer. Tommy then had an MRI-guided biopsy at Huntsman Cancer Institute (HCI), hoping there would be a more accurate result. Unfortunately, this biopsy did detect cancer. Fortunately, it was found early enough to treat.
Photopheresis treatment seems to modulate the immune system, not suppress it, allowing the body to manage graft-versus-host disease without counteracting the effects of the hematopoietic stem cell transplant.
HCI will start offering an innovative way to deliver chemotherapy to cancers that have spread to the lining of the abdominal cavity.
John Stringham, MD, recently joined Huntsman Cancer Institute and the University of Utah from University of Virginia Health System. A cardiothoracic surgeon, he specializes in lung transplant surgery and also has a special interest in lung cancer surgery for patients with lung failure. He discusses his interests in minimally invasive surgery and why HCI provides hope for patients with lung cancer.
A conversation with Anna Beck, MD—director of Supportive Oncology and Survivorship at Huntsman Cancer Institute—on a love for medicine that spans three generations and her four-legged family.